Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL

Clinical trial NCT01187810 · TERMINATED

Trial details

NCT number: NCT01187810
Sponsor: South Plains Oncology Consortium
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia Acute Lymphoblastic Leukemia Non-Hodgkin's Lymphoma

Start date: 2010-08-01
Primary completion: 2018-04-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.